Xeno Transplants Corporation
OTC: XENO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Elliot Lebowitz
- Headquarters
- Brookline, United States
- IPO year
- 2006
- Market cap
- $4.0K
- Website
- https://www.xenotransplants.com
Loading XENO…
Loading profile data…Frequently asked questions about XENO
What does Xeno Transplants Corporation (XENO) do?
Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary...
Where does XENO trade?
Xeno Transplants Corporation (XENO) trades on the Other OTC.
What sector is XENO in?
Xeno Transplants Corporation (XENO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xeno Transplants Corporation?
Elliot Lebowitz is the chief executive officer of Xeno Transplants Corporation (XENO).
Where is Xeno Transplants Corporation headquartered?
Xeno Transplants Corporation is headquartered in United States.
Does XENO pay a dividend?
Xeno Transplants Corporation (XENO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XENO go public?
Xeno Transplants Corporation (XENO) completed its initial public offering in 2006.